Información del producto
Nombre:
Indisetron
Sinónimos:
- N-[(7-endo)-3,9-dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl]-1H-indazole-3-carboxamideendo-N-(3,9-dimethyl-3,9-diazabicyclo[3.3.1]non- 7-yl)-1H-indazole-3-carboxamide
- 1H-Indazole-3-carboxamide, N-(3,9-dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl)-, endo-
- 1H-Indazole-3-carboxamide, N-[(7-endo)-3,9-dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl]-
- 3,9-Diazabicyclo[3.3.1]nonane, 1H-indazole-3-carboxamide deriv.
- Indisetron [INN]
- N-(3,9-Dimethyl-endo-3,9-diazabicyclo(3.3.1)non-7-yl)-1H-indazole-3-carboxamide
- N-(3,9-dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl)-1H-indazole-3-carboxamide
- N-[(7-endo)-3,9-Dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl]-1H-indazole-3-carboxamide
- Unii-89Rbz66Nvc
Descripción:
Indisetron is a drug that belongs to the group of low-potency antipsychotics. It is used in the treatment of cancer and other hyperproliferative disorders, as well as inflammatory bowel disease. Indisetron has been shown to have antiemetic properties in patients undergoing chemotherapy or other emetogenic procedures. This drug also has affinity constants for the neurokinin-1 receptor, which is an important factor in nausea and vomiting. Indisetron binds to this receptor and blocks its binding site, thereby inhibiting the production of serotonin that induces vomiting. This drug also has affinity constants for receptors on the brain stem, which may be responsible for its ability to relieve nausea and vomiting.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
313.4 g/mol
Fórmula:
C17H23N5O
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
